223 related articles for article (PubMed ID: 20399672)
1. Prognostic value of single nodal zone metastasis in non-small-cell lung cancer.
Kim MS; Lee HS; Lee JM; Zo JI; Lee GK; Nam BH
Eur J Cardiothorac Surg; 2010 Oct; 38(4):491-7. PubMed ID: 20399672
[TBL] [Abstract][Full Text] [Related]
2. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
[TBL] [Abstract][Full Text] [Related]
3. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
5. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
[TBL] [Abstract][Full Text] [Related]
6. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
[TBL] [Abstract][Full Text] [Related]
7. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
Huang GJ; Fang DK; Cheng GY; Zhang DC
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value and significance of subcarinal and superior mediastinal lymph node metastasis in lower lobe tumours.
Uehara H; Sakao Y; Mun M; Nakagawa K; Nishio M; Ishikawa Y; Okumura S
Eur J Cardiothorac Surg; 2010 Oct; 38(4):498-502. PubMed ID: 20381371
[TBL] [Abstract][Full Text] [Related]
11. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
[TBL] [Abstract][Full Text] [Related]
12. Prognostic evaluation of nodal staging based on the new IASLC lymph node map for lung cancer.
Takamochi K; Oh S; Suzuki K
Thorac Cardiovasc Surg; 2010 Sep; 58(6):345-9. PubMed ID: 20824587
[TBL] [Abstract][Full Text] [Related]
13. Non-small-cell lung cancer restaging with transcervical extended mediastinal lymphadenectomy.
Zieliński M; Hauer L; Hauer J; Nabiałek T; Szlubowski A; Pankowski J
Eur J Cardiothorac Surg; 2010 Apr; 37(4):776-80. PubMed ID: 20044265
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases.
Casali C; Stefani A; Natali P; Rossi G; Morandi U
Eur J Cardiothorac Surg; 2005 Jul; 28(1):33-8. PubMed ID: 15953734
[TBL] [Abstract][Full Text] [Related]
15. [The role of adjuvant therapy in the management of pN2 non-small-cell carcinoma of the lung].
Chella A; Lucchi M; Gragnani F; Ribechini A; Silvano G; Janni A; Mussi A; Angeletti CA
Minerva Chir; 1995 Dec; 50(12):1029-38. PubMed ID: 8725059
[TBL] [Abstract][Full Text] [Related]
16. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
17. Operative results of non-small cell lung cancer clinically presenting mediastinal lymph adenopathy.
Yoshino I; Yamaguchi M; Yohena T; Kameyama T; Kometani T; Osoegawa A; Maehara Y
Fukuoka Igaku Zasshi; 2003 Aug; 94(8):250-8. PubMed ID: 14579727
[TBL] [Abstract][Full Text] [Related]
18. Postrecurrence survival in patients with stage I non-small cell lung cancer.
Nakagawa T; Okumura N; Ohata K; Igai H; Matsuoka T; Kameyama K
Eur J Cardiothorac Surg; 2008 Sep; 34(3):499-504. PubMed ID: 18579404
[TBL] [Abstract][Full Text] [Related]
19. [Impact of TNM staging and treatment mode on the prognosis of non-small cell lung cancer].
Yu DP; Bai LQ; Xu SF; Han M; Wang ZT
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):465-8. PubMed ID: 19950561
[TBL] [Abstract][Full Text] [Related]
20. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
